Publications by authors named "Timothy Paradis"

Claim this Profile
E
Evaluation of antigen agnostic anti-tumor activity and immune memory induced by CBX-15 (alphalex-MMAE) in the rat.
Timothy Paradis, Qing Zhang, Laurie Tylaska, Connor Hagen, Theresa Pasqualini

Immunotherapy· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigen-independent tumor targeting by CBX-12 (alphalex-exatecan) induces long-term antitumor immunity.
Sophia Gayle, Timothy Paradis, Kelli Jones, Juan Vasquez, Vishwas M Paralkar

Immunotherapy· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to 'Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity'.
Sophia Gayle, Robert Aiello, Nalin Leelatian, Jason M Beckta, Jane Bechtold, Timothy Paradis

NAR Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity.
Sophia Gayle, Robert Aiello, Nalin Leelatian, Jason M Beckta, Jane Bechtold, Timothy Paradis

NAR Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice.
Ronald P Gladue, Timothy Paradis, Susan H Cole, Carol Donovan, Robin Nelson

Cancer Immunol Immunother· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Essential role of CCR6 in directing activated T cells to the skin during contact hypersensitivity.
Timothy J Paradis, Susan H Cole, Robin T Nelson, Ronald P Gladue

J Invest Dermatol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Piperazinyl CCR1 antagonists--optimization of human liver microsome stability.
Matthew F Brown, Kevin B Bahnck, Laura C Blumberg, William H Brissette, Sara A Burrell, Timothy J Paradis

Bioorg Med Chem Lett· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent small molecule CCR1 antagonists.
John C Kath, William H Brissette, Matthew F Brown, Maryrose Conklyn, Amy P DiRico, Timothy J Paradis

Bioorg Med Chem Lett· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel CCR1 antagonists with improved metabolic stability.
Matthew F Brown, Mike Avery, William H Brissette, J H Chang, Kevin Colizza, Timothy J Paradis

Bioorg Med Chem Lett· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases.
Ronald P Gladue, Laurie A Tylaska, William H Brissette, Paul D Lira, John C Kath, Timothy J Paradis

J Biol Chem· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis